Although the efficacy of EUS-FNA partly depends on the size and characteristics of the pancreatic mass as well as on the expertise, training and interaction between endosonographer and cytopathologist, the introduction of cell block procedure (CBP) may be considered an adequate additional diagnostic tool. [1] [2] [3] In fact, this technique allows better preservation of cell architecture with the achievement of routine hematoxylin-eosin staining and finally, the possibility to perform ancillary methods, such as immunohistochemistry or molecular analyses. [2, 3, 8, 9] In particular, CBP allows the availability of an adequate number of serial sections, with the chance to perform a precise immunohistochemical algorithm for the differential diagnostic purposes; however, also Alomari et al., [1] stressed the utilization of immunostained cell block sections in selective cases.
We report herein our recent personal unpublished experience concerning three cases of unusual solitary pancreatic solid masses without any documented or reported a history of malignancy elsewhere, obtained by EUS-FNA procedure from three male patients. The specimens were processed by a cytopathologist in-room and immediately examined for adequate cellularity after staining by Diff-Quick and hematoxylin and eosin. This rapid on-site evaluation showed a partially necrotic background with the presence of atypical cells, sometimes as tall columnar cells or arranged in glandular or pseudo-papillary structures, with irregular roundish hyperchromatic dense nuclei, sometimes with evident nucleoli, suggesting thus a diagnosis of positive for malignant cells. Further, the material additionally available Sir, We have read with great interest the paper entitled "Endoscopic ultrasound-guided fine-needle aspiration diagnosis of secondary tumors involving the pancreas: An institution's experience" by Alomari et al., [1] which appeared in CytoJournal 2016; 13:1. The authors reported a series of secondary tumors involving the pancreas, either by single or multiple masses, utilizing endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), also elsewhere considered yet as a safe and reliable diagnostic tool for pancreatic neoplastic lesions. [1] [2] [3] On the other hand, only a few reports have been addressed to study secondary tumors by EUS-FNA involving the pancreas. [1, [4] [5] [6] [7] We agree the presence of multiple pancreatic or suspicious metastatic lesions elsewhere in the body as well as the occurrence of a prior history of oncological malignancies represent significant clues to suspect the secondary nature of the pancreatic lesion. [1] The key diagnostic dilemma raises when secondary isolated neoplasms exhibit comparable morphological aspects with primary pancreatic carcinomas, mainly when an absent or unknown clinical history of previous neoplasia has been recognized. http://www.cytojournal.com/content/13/1/19 was treated for CBP [ Figure 1a] and then parallel-serial 5-µm sections were mounted on poly-lysine-coated glasses and submitted to immunocytochemical procedures. To verify the primitive or metastatic nature in each case, a set of the following commercially obtained monoclonal antisera was applied according to manufacturer's recommendations: Cytokeratin 7 (DakoCytomation, Copenhaghen, Denmark; working dilution 1:300), cytokeratin 20 (DakoCytomation; working dilution 1:300), carcinoembryonic antigen (CEA) (DakoCytomation; working dilution 1:500) and CDX2 (DakoCytomation; working dilution 1:50). All of the immunocytochemical reactions were carried out by using a standardized procedure with VENTANA Benchmark automatic immunostainer.
A diffuse and intense cytoplasmic immuno-positivity for cytokeratin 20, CEA and CDX2 was always encountered [ Figure 1b ], whereas cytokeratin 7 appeared constantly negative. Although CEA staining is not specific and reveals only a few additional support in the differentiation of metastatic colonic from pancreatic ductal adenocarcinoma, the observed immunoprofile was suggestive for a less common metastatic carcinoma coming from the colon, similarly to that reported in cases 16 and 17 by Alomari et al. [1] Consequently, we have investigated to obtain a detailed clinical information regarding the previous occurrence of colonic carcinomas. On this way, the close communication with patient's family and clinicians revealed that two sigmoid and one ascending colon carcinomas had been surgically removed more than 5 years before. Therefore, we fully agree with the suggestion of Alomari et al., [1] that the cytological examination is an extremely relevant aid to obtain an accurate diagnosis to differentiate the primary or metastatic nature of pancreatic neoplasms, taking into consideration the therapeutic treatment and prognosis should be greatly different to perform.
Finally, the identification and quantification of potential molecular markers may represent a promising field to be further investigated on the same biological samples collected by EUS-FNA CBP assisted since pancreatic metastases from colo-rectal carcinomas consist of a group of heterogeneous disorders with a large number of diverse sets of genetic changes in oncogenes and tumor suppressor genes. 
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